Researchers from Columbia Engineering have developed a system that temporarily disguises therapeutic bacteria from immune systems and allows them to deliver drugs to tumors and kill cancer cells in mice.
Looking for innovative drug delivery systems? Maybe expansive cell growth bioreactors? How about revolutionary gas sensing technology? With just 10 minutes in the spotlight, 10 Columbia Engineering startups recently offered up an array of incredible
Columbia University Irving Medical Center
Silver nanoclusters-which could be applied to the treatment of cancer in the future-block an early step of DNA replication, a new study by researchers in the Institute for Cancer Genetics at Columbia University Vagelos College of Physicians and Surgeons and the Herbert Irving Comprehensive Cancer Center has found.
Silver nanoclusters, which contain just a few to tens of atoms, are a more recent addition to the collection of silver nanomaterials, including larger-sized silver nanoparticles.
“In the long term, we may be able to harness the toxicity of silver nanoclusters.”
Because of silver nanoclusters’ unique chemical characteristics, they are used in a wide array of applications, including antimicrobial agents and electronics, and are being investigated for use in cancer imaging and drug delivery.